CRH Medical Stock Forecast for 2023 - 2025 - 2030

Updated on 05/01/2024

Stock Rating
10
Price Target
C$5.63
Consensus
-
Upside
12.83%
Analysts
0
Stock Rating
10
Upside
12.83%
Analysts
0
Price Target
C$5.63

CRH Medical Stock Forecast and Price Target

Given the average yearlong price target of C$5.63 provided by prominent analysts over the past few months, there is a potential upside of approximately 12.83% from the last closing price in May, 2021 for CRH Medical's stock if it is reached. This estimation is based on a high estimate of C$6.30 and a low estimate of C$5.01. Even if you are not interested in CRH stock, it is still imperative to be aware of its competitors.

C$5.63

12.83% Upside

-

CRH Medical Fair Value Forecast for 2023 - 2025 - 2030

In the last year, CRH Medical's Price has grown by 100.00%, rising from C$0.00 to C$0.00. For next year, analysts predict Fair Value of C$5.30, which would mean an increase of 100.00%. Over the next seven years, experts predict that CRH Medical's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
C$5.30
2025 Fair Value Forecast
C$5.80
2026 Fair Value Forecast
C$6.34
2027 Fair Value Forecast
C$6.93
2028 Fair Value Forecast
C$7.58
2029 Fair Value Forecast
C$8.29
2030 Fair Value Forecast
C$9.07

CRH Medical Revenue Forecast for 2023 - 2025 - 2030

CRH Medical Dividend per Share Forecast for 2023 - 2025 - 2030

CRH Medical Free Cash Flow Forecast for 2023 - 2025 - 2030

CRH Medical EBITDA Forecast for 2023 - 2025 - 2030

CRH Medical EBIT Forecast for 2023 - 2025 - 2030

CRH Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, CRH Medical's EPS has grown by 100.00%, rising from C$0.00 to C$0.00. For next year, analysts predict EPS of C$0.00, which would mean an increase of 100.00%. Over the next seven years, experts predict that CRH Medical's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
C$0.00
2025 EPS Forecast
C$0.00
2026 EPS Forecast
C$0.00
2027 EPS Forecast
C$0.00
2028 EPS Forecast
C$0.00
2029 EPS Forecast
C$0.00
2030 EPS Forecast
C$0.00